Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Midazolam, Repaglinide, Dextromethorphan, Metformin, Rosuvastatin and Dolutegravir
Clinical trial NCT05236530 · COMPLETED
Trial details
- NCT number
- NCT05236530
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-09
- Primary completion
- 2022-10-17
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.